Close
ACHEMA MIDDLE EAST 2026
5th LNP Formulation & Process Development Summit

Research & Development

Boehringer Ingelheim and University of Dundee collaborate to develop new class of medicines

Research & Development
• Collaboration aims to develop PROteolysis TArgeting Chimeric molecules (PROTACs) – a new therapeutic modality that is able to degrade proteins playing a central...

Health Canada approves Abbott’s Absorb Bioresorbable Stent

Research & Development
Abbott announced that Health Canada has approved the company's Absorb bioresorbable heart stent, making the first-of-its-kind medical device commercially available to treat people in...

Bayer and X-Chem Expand Drug Discovery Collaboration to Discover Novel Medicines

Research & Development
Bayer and X-Chem, Inc focused on applying its innovative drug discovery capabilities to the generation of novel small molecule therapeutics, have entered into an...

AbbVie Receives U.S. FDA Rare Pediatric Disease Designation for Investigational ABT

Research & Development
AbbVie a global biopharmaceutical company, announced that the U.S. FDA granted Rare Pediatric Disease Designation for ABT-414, an investigational antibody drug conjugate (ADC) targeting...

EC Grants Marketing Authorization for Gilead’s Epclusa for the Treatment of All Genotypes of Chronic Hepatitis C

Research & Development
Gilead Sciences, Inc announced that the European Commission has granted marketing authorization for Epclusa® (sofosbuvir 400 mg/velpatasvir 100 mg), the first pan-genotypic, single tablet...

Alere Inc q HIV-1/2 Detect Point-of-Care Molecular HIV Assay Receives WHO Prequalification

Research & Development
Alere Inc a global leader in rapid diagnostics, announced that its Alere™ q HIV-1/2 Detect assay has been awarded World Health Organization (WHO) prequalification,...

Norgine BV has received approval from the Dutch Ministry of Health of Xifaxan 550

Research & Development
Norgine B.V.  announced that the Ministry of Health in the Netherlands , Ministry van Volksgezondheid, Welzijn en Sport , has approved the reimbursement of...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

Whitepapers 0
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

Whitepapers 0
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Whitepapers 0
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

About us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

Resources

Advertise

Subscribe

Copyright © Value Media Group 2026. All rights reserved.